Skip to main content
Prilenia

Prilenia

biotechnology
1-10 employees
Since 2018
3 open positions

About Prilenia

Prilenia Therapeutics is a clinical stage biotech company developing its lead drug candidate, pridopidine, for Huntington’s Disease and ALS. It was founded in 2018 with the purpose of improving the lives of patients and their families by developing treatments for neurodegenerative and neurodevelopmental disorders.

Open Positions (3)

Company Details

Founded
2018(8 yrs)
Employees
1-10
Monthly Visitors
10K
Domain
prilenia.com